{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T15:43:47Z","timestamp":1758123827259},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.cancergencyto.2009.10.016","type":"journal-article","created":{"date-parts":[[2010,1,27]],"date-time":"2010-01-27T10:11:56Z","timestamp":1264587116000},"page":"25-31","source":"Crossref","is-referenced-by-count":9,"title":["E-cadherin\u2013160 C\/A promoter polymorphism and risk of pancreatic carcinoma in Chinese population"],"prefix":"10.1016","volume":"197","author":[{"given":"Yang","family":"Fei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xushun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieming","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2009.10.016_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/01.mpa.0000168220.97967.d1","article-title":"Current diagnosis and treatment of pancreatic cancer in China","volume":"31","author":"Guo","year":"2005","journal-title":"Pancreas"},{"key":"10.1016\/j.cancergencyto.2009.10.016_bib2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrc1881","article-title":"Ubiquitin ligases: cell-cycle control and cancer","volume":"6","author":"Nakayama","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cancergencyto.2009.10.016_bib3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/(SICI)1097-4652(199711)173:2<271::AID-JCP34>3.0.CO;2-G","article-title":"E-cadherin\/catenin\/cytoskeleton complex: a regulator of cancer invasion","volume":"173","author":"Mareel","year":"1997","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.cancergencyto.2009.10.016_bib4","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D","article-title":"Mutations of the human E-cadherin (CDH1) gene","volume":"12","author":"Berx","year":"1998","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cancergencyto.2009.10.016_bib5","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/32918","article-title":"E-cadherin germline mutations in familial gastric cancer","volume":"392","author":"Guilford","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.cancergencyto.2009.10.016_bib6","first-page":"594","article-title":"Frequent downregulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas","volume":"7","author":"Matsumura","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergencyto.2009.10.016_bib7","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ijc.1208","article-title":"Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast","volume":"92","author":"Droufakou","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cancergencyto.2009.10.016_bib8","first-page":"5195","article-title":"E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas","volume":"55","author":"Graff","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergencyto.2009.10.016_bib9","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.1073\/pnas.92.16.7416","article-title":"Silencing of the E-cadherin invasion suppressor gene by CpG methylation in human carcinomas","volume":"92","author":"Yoshiura","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cancergencyto.2009.10.016_bib10","first-page":"5021","article-title":"Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma","volume":"60","author":"Eads","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergencyto.2009.10.016_bib11","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/bjs.1800831138","article-title":"Decreased E-cadherin expression is associated with haematogenous recurrence and poor prognosis in patients with squamous-cell carcinoma of the oesophagus","volume":"83","author":"Tamura","year":"1996","journal-title":"Br J Surg"},{"key":"10.1016\/j.cancergencyto.2009.10.016_bib12","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/jcp.50.8.640","article-title":"Expression of E-cadherin in oesophageal carcinomas from the UK and China: disparities in prognostic significance","volume":"50","author":"Jian","year":"1997","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.cancergencyto.2009.10.016_bib13","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1073\/pnas.96.5.2316","article-title":"Mutated epithelial cadherin is associated with increased tumorigenicity and loss of adhesion and of responsiveness to the motogenic trefoil factor 2 in colon carcinoma cells","volume":"96","author":"Efstathiou","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cancergencyto.2009.10.016_bib14","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/(SICI)1096-9896(199904)187:5<530::AID-PATH293>3.0.CO;2-C","article-title":"Functional loss of E-cadherin and cadherin-11 alleles on chromosome 16q22 in colonic cancer","volume":"187","author":"Braungart","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.cancergencyto.2009.10.016_bib15","first-page":"873","article-title":"A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities","volume":"60","author":"Li","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergencyto.2009.10.016_bib16","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"Miller","year":"1998","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cancergencyto.2009.10.016_bib17","first-page":"235","article-title":"Expression of E-cadherin in pancreatic carcinoma and its association with angiogenesis","volume":"6","author":"Yang","year":"2009","journal-title":"Chin J Hepatobiliary Surg"},{"key":"10.1016\/j.cancergencyto.2009.10.016_bib18","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/ijc.10590","article-title":"CDH1 c-160a promoter polymorphism is not associated with risk of stomach cancer","volume":"101","author":"Pharoah","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cancergencyto.2009.10.016_bib19","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/jjco\/hyi040","article-title":"Association of a genetic polymorphism of the E-cadherin gene with prostate cancer in a Japanese population","volume":"35","author":"Kamoto","year":"2005","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.cancergencyto.2009.10.016_bib20","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/ijc.11705","article-title":"E-cadherin polymorphism\u2013160 C\/A and prostate cancer","volume":"109","author":"Hajdinjak","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cancergencyto.2009.10.016_bib21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.lungcan.2008.03.023","article-title":"Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer","volume":"62","author":"Wang","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cancergencyto.2009.10.016_bib22","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3346\/jkms.2003.18.4.501","article-title":"A single nucleotide polymorphism in the E-cadherin gene promoter\u2013160 is not associated with risk of Korean gastric cancer","volume":"18","author":"Park","year":"2003","journal-title":"J Kor Med Sci"},{"key":"10.1016\/j.cancergencyto.2009.10.016_bib23","first-page":"35","article-title":"The E-cadherin gene polymorphism \u2212160C\/A and epithelial ovarian cancer risk","volume":"2","author":"Wang","year":"2007","journal-title":"Chin. J.\u00a0Gynecol Oncol"},{"key":"10.1016\/j.cancergencyto.2009.10.016_bib24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0960-7404(01)00010-X","article-title":"E-cadherin complex and its abnormalities in human breast cancer","volume":"9","author":"Jiang","year":"2000","journal-title":"Surg Oncol"},{"key":"10.1016\/j.cancergencyto.2009.10.016_bib25","first-page":"563","article-title":"alternative transcripts [a] and [b] are expressed in normal and malignant lymphocytes and their relative levels are influenced by the polymorphism at codon -160 of E-cadherin","volume":"86","author":"Li","year":"2005","journal-title":"Chin J\u00a0Hematol Oncol"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460809006104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460809006104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T17:24:53Z","timestamp":1544721893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460809006104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0165460809006104"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2009.10.016","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}